A cohort study found different prescribing patterns among nurse practitioners who obtained a historical buprenorphine waiver, without isolating the effect of training.
The investigators linked Oregon prescribing-monitoring and licensure records from 2016–2018. Benzodiazepine-opioid co-prescribing declined more among waivered practitioners than among non-waivered practitioners, while other controlled-substance measures changed differently. Baseline professional and prescribing characteristics also differed.
Waiver acquisition and training were not randomized. Patient mix, specialty, and transitions into addiction care can influence comparisons. The historical regulatory context is part of the study design and should not be presented as current law or current prescribing requirements.
For a prescribing-quality opinion, identify the measured outcome and the pre-existing differences between groups. The paper does not prove that one educational requirement caused safer care or that a specific co-prescription was improper. Patient-level indication and actual overlap still need review.
Source reviewed: The impact of CARA mandates on nurse practitioner controlled substance prescribing in Oregon a cohor (PMC8805433). Forensic applications above are interpretive analysis of the supplied paper.
Related reading: Japanese Prescribing-Restriction Study Was a Historical Single-Center Comparison; Hip-Fracture Payment Study Found Changes in Post-Discharge Psychotropic Prescribing.